Test Price
2,800 AEDโ Home Collection Available
๐ Results in 3โ4 Weeks
SGCE Gene DYT11 (Myoclonus-Dystonia) Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
The SGCE Gene DYT11 NGS Sequencing test provides a definitive molecular diagnosis for myoclonus-dystonia syndrome using Next-Generation Sequencing technology. This certified diagnostic solution offers unmatched precision for hereditary movement disorder evaluation.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance with a DHA-licensed genetics consultant to interpret results.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This test leverages Next-Generation Sequencing (NGS) to analyse the entire coding region, splice sites, and known deep intronic mutations of the SGCE gene. It provides a comprehensive and definitive molecular diagnosis for myoclonus-dystonia syndrome (DYT11), enabling targeted therapeutic management and precise genetic counselling.
| Feature | Our Test (SGCE DYT11 NGS) | Closest Alternative (Targeted Sanger Panel) |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) โ full gene analysis | Sanger sequencing (single-exon or hotspot testing) |
| Coverage | Complete coding exons, splice sites, and known deep intronic mutations | Limited to specific, pre-selected mutations |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks |
| Clinical Interpretation | Comprehensive report with genetic counselling integration & DHA guidelines | Basic mutation report without structured clinical guidance |
Physician Insight & Safety Protocols
โAs a geneticist specializing in movement disorders, I understand the emotional weight of seeking a molecular diagnosis for myoclonus-dystonia. A positive SGCE DYT11 result provides a clear explanation, but your clinical journey is unique. This test empowers your neurologist to tailor therapy and provide the safest, most effective care.โ
โ Consultant Medical Genetics Lina Osama Zaki Quteineh, DHA Registration ID: 9294403
Important Advisory
Do not discontinue prescribed medication without consulting your physician. This genetic test is for diagnostic confirmation and clinical guidance, not for unsupervised treatment modification.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Recent allogeneic bone marrow transplant may confound DNA analysis; sample collection is deferred for six months post-transplant.
- Exclusion: Active chemotherapy that could degrade sample quality; consult oncologist before collecting blood.
- Red Flag: Sudden severe worsening of dystonia causing respiratory distress or inability to swallow โ seek emergency care immediately.
- Red Flag: New-onset status myoclonus unresponsive to home management โ proceed to the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the SGCE gene DYT11 Genetic Test and what does it detect?
This test precisely sequences the entire coding region of the SGCE gene using Next-Generation Sequencing to identify pathogenic variants causing myoclonus-dystonia syndrome (DYT11), a hereditary movement disorder. The test provides a definitive molecular diagnosis with 99.9% sensitivity.
2. How is the sample collected and can it be done at home?
A simple, virtually painless blood draw or saliva sample is collected by our DHA-licensed phlebotomist during your VIP home visit within the Temperature-Controlled Cold-Chain logistics framework. Home collection is available daily from 8 AM to 11 PM.
3. When will I receive results and what should I expect in the report?
Results are delivered in 3โ4 weeks with a clear, actionable report including variant interpretation, clinical correlation, and precise genetic counselling recommendations integrated with DHA clinical guidelines.
UAE Regulatory & Data Privacy Adherence
This testing process and data handling are fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
DNA Labs UAE operates under DHA Facility License Number: 1143, ensuring all diagnostic processes meet the highest standards of clinical accuracy and patient safety in Dubai Healthcare City.
Clinical & Logistical Metadata
| Test Name | SGCE Gene DYT11 NGS Sequencing |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral Blood, Saliva (Oragene OG-500), or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS), Full Gene Analysis |
| ICD-10-CM Code | G24.8 |
| LOINC Code | 97961-3 |
| DHA Facility License & Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DHA License: 1143 |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["No specific fasting required", "Inform lab of any recent bone marrow transplant or active chemotherapy"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians